New immunotherapy regimen approved for the treatment of historically untreatable triple negative breast cancer.
Oncologist Meredith McKean, MD, MPH, overseeing Sarah Cannon's Melanoma Research Program
Genetics playing a significant role in the future of lung cancer treatment.
It's a diagnosis everyone fears, but Tennessee Oncology and Sarah Cannon physician-scientist Erika P. Hamilton, MD said advances in clinical care and research are helping turn the tide on cancer.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: